Progress in specific-targeting hepatic stellate cell of liver fibrosis therapy

Liver fibrosis is a chronic liver disease development process to go through a histological change.Hepatic stellate cell(HSC) is the central link in the activation and proliferation of liver fibrosis.Recent studies indicate that regulating gene therapy and receptor-mediated medicine can be used in targeting HSC,which will further improve liver specificity and develop new approach to clinical application.